Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury

Cell Death and Disease

Volumn 6, Issue 4, 2015, Pages

  Noro, T ^a,b   Namekata, K ^a   Kimura, A ^a   Guo, X ^a   Azuchi, Y ^a   Harada, C ^a   Nakano, T ^b   Tsuneoka, H ^b   Harada, T ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPROTECTIVE AGENT; SPERMIDINE;

ADULT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; IN VIVO STUDY; LONGITUDINAL STUDY; MICROGLIA; MOUSE; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; OPTIC NERVE INJURY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA GANGLION CELL; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; OPTIC NERVE INJURIES; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL; NERVE REGENERATION; OPTIC NERVE INJURIES; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION; SPERMIDINE;

EID: 84989954600     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.93     Document Type: Article

References (56)

1. Steinsapir KD, Goldberg RA. Traumatic optic neuropathy. Surv Ophthalmol 1994; 38: 487-518.
2. Sarkies N. Traumatic optic neuropathy. Eye (Lond) 2004; 18: 1122-1125.
3. Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology 1999; 106: 1268-1277.
4. Parrilla-Reverter G, Agudo M, Sobrado-Calvo P, Salinas-Navarro M, Villegas-Perez MP, Vidal-Sanz M. Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study. Exp Eye Res 2009; 89: 32-41.
5. Park K, Luo JM, Hisheh S, Harvey AR, Cui Q. Cellular mechanisms associated with spontaneous and ciliary neurotrophic factor-cAMP-induced survival and axonal regeneration of adult retinal ganglion cells. J Neurosci 2004; 24: 10806-10815.
6. Namekata K, Harada C, Taya C, Guo X, Kimura H, Parada LF et al. Dock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex. Proc Natl Acad Sci USA 2010; 107: 7586-7591.
7. Tonari M, Kurimoto T, Horie T, Sugiyama T, Ikeda T, Oku H. Blocking endothelin-B receptors rescues retinal ganglion cells from optic nerve injury through suppression of neuroinflammation. Invest Ophthalmol Vis Sci 2012; 53: 3490-3500.
8. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-267.
9. John SW, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull D et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2 J mice. Invest Ophthalmol Vis Sci 1998; 39: 951-962.
10. WoldeMussie E, Ruiz G, Wijono M, Wheeler LA. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci 2001; 42: 2849-2855.
11. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 1995; 61: 33-44.
12. Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res 1997; 64: 85-96.
13. Harada T, Harada C, Nakamura K, Quah HM, Okumura A, Namekata K et al. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest 2007; 117: 1763-1770.
14. Harada C, Namekata K, Guo X, Yoshida H, Mitamura Y, Matsumoto Y et al. ASK1 deficiency attenuates neural cell death in GLAST-deficient mice, a model of normal tension glaucoma. Cell Death Differ 2010; 17: 1751-1759.
15. Semba K, Namekata K, Guo X, Harada C, Harada T, Mitamura Y. Renin-angiotensin system regulates neurodegeneration in a mouse model of normal tension glaucoma. Cell Death Dis 2014; 5: e1333.
16. Semba K, Namekata K, Kimura A, Harada C, Mitamura Y, Harada T. Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma. Cell Death Dis 2014; 5: e1341.
17. Laube G, Veh RW. Astrocytes, not neurons, show most prominent staining for spermidine/ spermine-like immunoreactivity in adult rat brain. Glia 1997; 19: 171-179.
18. Biedermann B, Skatchkov SN, Bringmann A, Pannicke T, Veh R, Bernstein H-G et al. Spermine/Spermidine is expressed by retinal glial (Müller) cells, and controls distinct K+ channels of their membrane. Glia 1998; 23: 209-220.
19. Rider JE, Hacker A, Mackintosh CA, Pegg AE, Woster PM, Casero RA Jr. Spermine and spermidine mediate protection against oxidative damage caused by hydrogen peroxide. Amino Acids 2007; 33: 231-240.
20. Eisenberg T, Knauer H, Schauer A, Buttner S, Ruckenstuhl C, Carmona-Gutierrez D et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol 2009; 11: 1305-1314.
21. Guo X, Harada C, Namekata K, Kimura A, Mitamura Y, Yoshida H et al. Spermidine alleviates severity of murine experimental autoimmune encephalomyelitis. Invest Ophthalmol Vis Sci 2011; 52: 2696-2703.
22. Katome T, Namekata K, Guo X, Semba K, Kittaka D, Kawamura K et al. Inhibition of ASK1- p38 pathway prevents neural cell death following optic nerve injury. Cell Death Differ 2013; 20: 270-280.
23. Semba K, Namekata K, Kimura A, Harada C, Katome T, Yoshida H et al. Dock3 overexpression and p38 MAPK inhibition synergistically stimulate neuroprotection and axon regeneration after optic nerve injury. Neurosci Lett 2014; 581: 89-93.
24. Kimura A, Namekata K, Guo X, Noro T, Harada C, Harada T. Valproic acid prevents NMDAinduced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling. Am J Pathol 2015; 185: 756-764.
25. Hattori K, Naguro I, Runchel C, Ichijo H. The roles of ASK family proteins in stress responses and diseases. Cell Commun Signal 2009; 7: 9.
26. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007; 8: 57-69.
27. Brown GC, Neher JJ. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 2010; 41: 242-247.
28. Soga M, Matsuzawa A, Ichijo H. Oxidative stress-induced diseases via the ASK1 signaling pathway. Int J Cell Biol 2012; 2012: 439587.
29. Kawarazaki Y, Ichijo H, Naguro I. Apoptosis signal-regulating kinase 1 as a therapeutic target. Expert Opin Ther Targets 2014; 18: 651-664.
30. Kikuchi M, Tenneti L, Lipton SA. Role of p38 mitogen-activated protein kinase in axotomyinduced apoptosis of rat retinal ganglion cells. J Neurosci 2000; 20: 5037-5044.
31. Guo X, Harada C, Namekata K, Matsuzawa A, Camps M, Ji H et al. Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway. EMBO Mol Med 2010; 2: 504-515.
32. Goyal A, Srivastava A, Sihota R, Kaur J. Evaluation of oxidative stress markers in aqueous humor of primary open angle glaucoma and primary angle closure glaucoma patients. Curr Eye Res 2014; 39: 823-829.
33. Inman DM, Lambert WS, Calkins DJ, Horner PJ. alpha-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction. PLoS One 2013; 8: e65389.
34. Rieck J. The pathogenesis of glaucoma in the interplay with the immune system. Invest Ophthalmol Vis Sci 2013; 54: 2393-2409.
35. Mosher KI, Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer's disease. Biochem Pharmacol 2014; 88: 594-604.
36. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410: 988-994.
37. Yang G, Meng Y, Li W, Yong Y, Fan Z, Ding H et al. Neuronal MCP-1 mediates microglia recruitment and neurodegeneration induced by the mild impairment of oxidative metabolism. Brain Pathol 2011; 21: 279-297.
38. Skatchkov SN, Woodbury-Farina MA, Eaton M. The role of glia in stress: polyamines and brain disorders. Psychiatr Clin North Am 2014; 37: 653-678.
39. Williams K. Modulation and block of ion channels: a new biology of polyamines. Cell Signal 1997; 9: 1-13.
40. Inyushin MY, Huertas A, Kucheryavykh YV, Kucheryavykh LY, Tsydzik V, Sanabria P et al. L-DOPA uptake in astrocytic endfeet enwrapping blood vessels in rat brain. Parkinsons Dis-US 2012; 2012: 321406.
41. Sala-Rabanal M, Li DC, Inyushin M, Skatchkov SN, Nichols CG. Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2 and OCT3. Mol. Pharm. 2013; 10: 1450-1458.
42. Hiasa M, Miyaji T, Haruna Y, Takeuchi T, Harada Y, Moriyama S et al. Identification of a mammalian vesicular polyamine transporter. Sci Rep 2014; 4: 6836.
43. Benedikt J, Inyushin M, Kucheryavykh YV, Rivera Y, Kucheryavykh LY, Nichols CG et al. Intracellular polyamines enhance astrocytic coupling. NeuroReport 2012; 23: 1021-1025.
44. Danesh-Meyer HV, Kerr NM, Zhang J, Eady EK, O'Carroll SJ, Nicholson LF et al. Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia. Brain 2012; 135: 506-520.
45. Harada T, Harada C, Nakayama N, Okuyama S, Yoshida K, Kohsaka S et al. Modification of glial-neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration. Neuron 2000; 26: 533-541.
46. Harada T, Harada C, Kohsaka S, Wada E, Yoshida K, Ohno S et al. Microglia-Muller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci 2002; 22: 9228-9236.
47. Harada C, Guo X, Namekata K, Kimura A, Nakamura K, Tanaka K et al. Glia- and neuronspecific functions of TrkB signalling during retinal degeneration and regeneration. Nat Commun 2011; 2: 189.
48. de Lima S, Koriyama Y, Kurimoto T, Oliveira JT, Yin Y, Li Y et al. Full-length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviors. Proc Natl Acad Sci USA 2012; 109: 9149-9154.
49. Namekata K, Kimura A, Kawamura K, Harada C, Harada T. Dock GEFs and their therapeutic potential: Neuroprotection and axon regeneration. Prog Retin Eye Res 2014; 43: 1-16.
50. Pernet V, Schwab ME. Lost in the jungle: new hurdles for optic nerve axon regeneration. Trends Neurosci 2014; 37: 381-387.
51. Deng K, He H, Qiu J, Lorber B, Bryson JB, Filbin MT. Increased synthesis of spermidine as a result of upregulation of arginase I promotes axonal regeneration in culture and in vivo. J Neurosci 2009; 29: 9545-9552.
52. Soda K, Kano Y, Sakuragi M, Takao K, Lefor A, Konishi F. Long-term oral polyamine intake increases blood polyamine concentrations. J Nutr Sci Vitaminol (Tokyo) 2009; 55: 361-366.
53. Bell MR, Belarde JA, Johnson HF, Aizenman CD. A neuroprotective role for polyamines in a Xenopus tadpole model of epilepsy. Nat Neurosci 2011; 14: 505-512.
54. Harada C, Nakamura K, Namekata K, Okumura A, Mitamura Y, Iizuka Y et al. Role of apoptosis signal-regulating kinase 1 in stress-induced neural cell apoptosis in vivo. Am J Pathol 2006; 168: 261-269.
55. Namekata K, Harada C, Guo X, Kimura A, Kittaka D, Watanabe H et al. Dock3 stimulates axonal outgrowth via GSK-3beta-mediated microtubule assembly. J Neurosci 2012; 32: 264-274.
56. Guo X, Nakamura K, Kohyama K, Harada C, Behanna HA, Watterson DM et al. Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis. Neurosci Res 2007; 59: 457-466.